LIS Technologies
New York
About LIS Technologies
LIS Technologies specializes in Laser Isotope Separation Technology (L.I.S.T), focusing on laser uranium enrichment. It is noted for being the only patented technology of its kind originating from the USA. The Laser Isotope Separation Technology (L.I.S.T) offers a broad spectrum of uses, notably being the only US-based (and patented) company for laser uranium enrichment. It boasts several significant advantages over conventional techniques like gas diffusion, centrifuges, and previous laser enrichment methods. The proprietary laser-driven process of L.I.S.T is more energy-efficient and has the potential for deployment with highly competitive capital and operating costs. L.I.S.T is tailored for Low Enriched Uranium (LEU) utilized in current civilian nuclear power plants, High-Assay LEU (HALEU) for the future Small Modular Reactors (SMR) and Microreactors, stable isotope production for medical and scientific research, and contributions to quantum computing manufacturing for semiconductor technologies. The company employs a top-tier nuclear technical team collaborating with leading nuclear entrepreneurs and industry experts, maintaining robust connections with governmental and private nuclear sectors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $64.4M
- Last round: Series Unknown (Jan 2026)
- Website: laseristech.com
- Phone: +1 800-388-5492
Industries & Categories
Laser, Manufacturing, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/lis-technologies-61504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.